# TargetX — Roadmap for World-Class Accuracy & Advanced AI/ML Infrastructure

This document outlines the **advanced deep learning architectures**, **genomic foundation models**, **structural biophysics tools**, and **multi-omics datasets** required to push TargetX to state-of-the-art predictive accuracy ($R^2 > 0.88 - 0.92$) and maximum clinical/industrial impact.

---

## 1. Scientific Clarification: The "100% Accuracy" Horizon in Biology

In experimental molecular biology, **100% theoretical accuracy is bounded** due to wet-lab biological variance (transfection efficiency, cell cycle phase $G_1/S/G_2/M$, cell-type specific epigenetic state, and sequencing noise). 

However, **"Effectively 100% Actionable Accuracy"** (zero bench failure rates) is achieved when:
1. Predicting **Top-3 gRNA candidates** backed by multi-model consensus ($S_{ensemble} > 0.85$).
2. Filtering out all off-targets with **chromatin-aware open region checking**.
3. Modeling **exact DNA repair outcomes** (InDel distributions via microhomology).

---

## 2. Advanced Deep Learning & Genomic Foundation Models

To go beyond tree-based models (XGBoost/LightGBM) and capture complex non-linear genomic physics, the following models should be integrated into TargetX:

```
                                  TargetX Next-Gen AI Pipeline
                                               │
 ┌───────────────────────────────┬─────────────┴───────────────┬───────────────────────────────┐
 │                               │                             │                               │
 ▼                               ▼                             ▼                               ▼
[1. Genomic Foundation]   [2. Deep Sequence AI]      [3. 3D Structural Biophysics]  [4. DNA Repair Outcome]
- DNABERT-2               - DeepHF (High Fidelity)   - AlphaFold 3                  - inDelphi / FORECas
- Nucleotide Transformer   - CRISPR-Net (Attention)   - ViennaRNA (Hairpin ΔG)       - SPROUT (T-cell HDR)
- Evo (7B Foundation)     - DeepCRISPR (CNN-Auto)    - NUPACK (Duplex Thermodynamics)
```

### 2.1 Genomic Foundation Models (Pretrained LLMs for DNA)

| Model Name | Developer / Source | Architecture | Unique Capability for TargetX |
| :--- | :--- | :--- | :--- |
| **DNABERT-2** | *Illumina / Penn State* | BPE-tokenized Transformer | Pretrained on multi-species genomes. Understands non-coding regulatory syntax and long-range promoter-enhancer interactions ($>10 \text{kb}$). |
| **Nucleotide Transformer** | *InstaDeep / BioNeMo* | 2.5B Parameter Transformer | State-of-the-art genomic embeddings for predicting chromatin accessibility and gene expression changes post-cut. |
| **Evo** | *Arc Institute / Stanford* | 7B StripedHyena Architecture | Biological foundation model operating at single-nucleotide resolution across DNA, RNA, and proteins. |

### 2.2 Specialized Deep Learning Models for CRISPR

| Model | Purpose | Features & Architecture |
| :--- | :--- | :--- |
| **DeepHF** | High-Fidelity Cas9 Scoring | Deep 1D CNN trained on $>50,000$ gRNAs for SpCas9, eSpCas9(1.1), and SpCas9-HF1 variants. |
| **CRISPR-Net** | Off-Target Cleavage | Recurrent Convolutional Neural Network (RCNN) + Attention mechanism for mismatch and RNA/DNA bulges. |
| **DeepCRISPR** | End-to-End Deep Learning | Unsupervised deep autoencoder extracting hybrid sequence + epigenetic features automatically. |

### 2.3 Structural Biophysics & RNA Thermodynamics

| Tool / Model | Input Data | Output Metric | Impact on TargetX |
| :--- | :--- | :--- | :--- |
| **ViennaRNA (`RNAfold`)** | gRNA 20nt + Scaffold | Minimum Free Energy ($\Delta G \text{ kcal/mol}$) | Detects guide self-folding hairpins that block Cas9 loading. |
| **NUPACK** | Target DNA + gRNA | Duplex Melting Temp ($T_m$), Unwinding Energy | Calculates exact DNA unwinding energy required for Cas9 strand invasion. |
| **AlphaFold 3 / ESMFold** | Cas9 Variant + Target DNA | 3D PDB Atomic Coordinates | Models spatial steric hindrance and protein-DNA binding kinetics. |

---

## 3. Advanced Multi-Omics & Cell-Type Specific Datasets

To achieve cell-type specific precision (e.g. T-cell therapy vs. iPSCs vs. Cancer lines), TargetX requires multi-omics data layers:

### 3.1 Chromatin Accessibility Datasets (ENCODE & Roadmap)

| Dataset | Cell Types Covered | Data Format | TargetX Function |
| :--- | :--- | :--- | :--- |
| **ENCODE ATAC-seq Signals** | K562, HEK293, HepG2, Primary T-cells, iPSCs | BigWig / BED | Penalizes target sites located in tightly packed heterochromatin (where Cas9 cannot physically access DNA). |
| **ChIP-seq Histone Marks** | H3K4me3 (Promoters), H3K27ac (Enhancers), H3K9me3 (Repressive) | BigWig | Enhances efficiency prediction based on active transcription chromatin states. |

### 3.2 InDel & Repair Outcome Prediction Datasets

| Dataset | Size | Purpose |
| :--- | :--- | :--- |
| **inDelphi Dataset (Shen et al. 2018)** | $>1,500$ target sites | Predicts exact microhomology-mediated repair deletion patterns (Frameshift % vs In-frame % knockout). |
| **FORECas (Allen et al. 2018)** | $>40,000$ target sites | Machine learning prediction of insertion/deletion mutations for target sequence cuts. |
| **SPROUT (Leenay et al. 2019)** | Primary human T-cells | Specific repair outcome dataset in primary immune cells for CAR-T therapeutics. |

### 3.3 Next-Gen Editing Modalities (Base & Prime Editing)

| Modality | Datasets Required | Key Models |
| :--- | :--- | :--- |
| **Base Editing (CBE / ABE)** | Kim et al. 2020 (Base Editing Screens) | **BE-Score / DeepBaseEditor**: Predicts C $\rightarrow$ T or A $\rightarrow$ G conversion window without double-strand breaks. |
| **Prime Editing (pegRNA)** | Kim et al. 2021 (Prime Editing Screens) | **DeepPRIME**: Predicts pegRNA extension efficiency, PBS length, and RT template optimization. |

---

## 4. Implementation Roadmap for High Impact

```
Phase 1: Baseline GBDT Ensemble (CURRENT - COMPLETE)
├── XGBoost + LightGBM + Random Forest
└── Azimuth & CRISPRon Datasets (R² ~ 0.70)

Phase 2: Thermodynamic & Biophysical Integration (IMMEDIATE)
├── ViennaRNA (RNAfold) ΔG Integration
├── InDelphi Microhomology Repair Outcome Scoring
└── ENCODE Cell-Type Chromatin Accessibility Masks (R² ~ 0.80)

Phase 3: Genomic Foundation Models & Clinical Grade (HIGH IMPACT)
├── DNABERT-2 / Nucleotide Transformer Feature Embeddings
├── Base Editing (CBE/ABE) & Prime Editing (pegRNA) Engines
└── Clinical-grade Off-Target Safety Certification (R² > 0.88)
```

---

*Document created for TargetX platform — High-Impact AI Architecture Specification*
